Shop by goal
Popular compounds
Research resources
Recently viewed
Sermorelin: HGH / Somatropin research guide
Not medical advice. Sermorelin is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.
What Sermorelin is
Sermorelin is the synthetic 29-amino-acid N-terminal fragment of GHRH and the shortest peptide that still acts as a full growth hormone releasing hormone receptor agonist.
One-paragraph overview from our research datasheet — still scientific, but faster to read than the full mechanism list below.
Sermorelin (GHRH 1-29), truncated growth hormone-releasing hormone fragment retaining full GHRHR agonist activity for pulsatile GH research.
Research contexts
Peer-reviewed literature typically discusses Sermorelin in specific experimental settings. The points below reflect how the scientific community frames this compound—not as health claims, but as the research questions being asked.
Research vs. personal use: Literature describes experiments in controlled lab and animal models. This is distinct from any real-world use; our products are for laboratory research only.
Typical study contexts
Why HGH / Somatropin research matters
Growth-hormone axis peptides are researched for how they signal through the GH/IGF pathway in animals and cells. Studies focus on endocrine biology and metabolism, not on prescribing or outcomes in people.
Mechanisms (technical review)
Our datasheet lists mechanistic themes observed in preclinical work. These are research endpoints, not health claims. They help scientists understand and compare pathways.
Lab handling & preparation
Storage requirements: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation. · Learn best practices in our detailed storage guide.
Research dosing context: Literature typically discusses 100–300 mcg subcutaneously · Once daily at bedtime to augment nocturnal GH pulsatility · IV/SC t½ ≈ 11–12 min; Tmax = 5–20 min (SC); absolute bioavailability ~6% (SC); clearance 2.4–2.8 L/min; Vd = 23.7–25.8 L; GH elevation persists ~3 h despite rapid peptide clearance. Intranasal bioavailability only 3–5%.
Preparation steps: Follow our detailed reconstitution guide, use the calculator tool for volume confirmation, and always verify purity with the COA reading guide.
Common Questions People Are Asking
What is sermorelin?
Sermorelin is a synthetic 29-amino-acid peptide corresponding to the active fragment of growth-hormone-releasing hormone (GHRH 1-29). It signals the pituitary to release its own growth hormone. It is supplied as a lyophilised research-grade powder for laboratory use only.
What does sermorelin do?
In research models sermorelin binds the pituitary GHRH receptor and prompts a natural, pulse-like release of growth hormone (and downstream IGF-1), rather than supplying GH directly. These are findings in research models; New-U supplies it for laboratory research only and implies no human therapeutic effect.
Does sermorelin work?
Sermorelin is a well-characterised GHRH analogue and reliably stimulates pituitary GH release in published studies, which is why it is so widely researched. Effectiveness for any human outcome is a separate, medically-supervised question outside our scope — it is sold strictly as a research compound.
What is sermorelin used for?
In the research literature sermorelin is used as a tool compound to study the GH/IGF-1 axis, pituitary function and body-composition endpoints, often paired with a ghrelin-receptor agonist such as ipamorelin. New-U supplies it strictly for in-vitro and animal-model research; it is not for human use.
Is sermorelin safe?
Sermorelin has a long research and (historically) clinical record as a GHRH analogue, but research-grade material is not an approved sterile medicine and carries no human safety assurances. New-U supplies it for laboratory research only and makes no human-use or safety claims.
Is sermorelin FDA approved?
Sermorelin was historically FDA-approved (as Geref) but that branded product was discontinued; it is no longer marketed as an approved drug, though it remains available through compounding pharmacies by prescription. New-U's sermorelin is research-grade material supplied for laboratory research only — not an approved medicine and not for human use.
How is sermorelin different from exogenous HGH?
HGH is the finished hormone and directly activates the GH receptor on every tissue. Sermorelin works one step upstream - it tells the pituitary to secrete its own GH in a physiologic pulse, preserving somatostatin feedback. That generally produces a more natural release pattern but a lower peak than direct HGH dosing.
Why is sermorelin usually dosed at bedtime?
The body naturally releases most of its GH during early deep sleep via a hypothalamic GHRH pulse. Evening dosing of sermorelin aligns the induced pulse with this natural rhythm, amplifying the physiologic nocturnal surge rather than creating a new one at an unusual time.
Can sermorelin be combined with ipamorelin or another GHRP?
Yes - combining a GHRH analog with a ghrelin-receptor agonist is a common research pairing. The two mechanisms are complementary (GHRHR plus GHSR), and the combined GH release is larger than either peptide alone in published studies.
How should sermorelin be stored?
Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water, refrigerate at 1-6 °C and protect from light. Sermorelin is relatively stable once reconstituted but should be used within the standard peptide-stability window.
What are the researched benefits of sermorelin?
In the clinical and preclinical literature, sermorelin-induced GH release has been studied for downstream effects on the GH/IGF-1 axis - body composition, sleep architecture, recovery markers and IGF-1 elevation - while preserving the pituitary's own somatostatin feedback. These are research findings; sermorelin is not sold for human use and New-U makes no therapeutic claims.
What sermorelin dosage is described in the research literature?
Published research and the historical clinical record (sermorelin was once marketed as Geref) describe microgram-to-low-milligram subcutaneous amounts once daily, typically at night to match the natural nocturnal GH pulse. New-U publishes this only as descriptive research context - it is not a dosing instruction, and sermorelin is supplied strictly for laboratory research, not human use.
What side effects are reported with sermorelin in studies?
The research and historical clinical literature most commonly note injection-site reactions (redness, swelling), occasional flushing, headache or transient dizziness; serious effects are uncommon at the amounts studied because the pituitary's own feedback caps GH output. This is summarised research context, not medical advice - sermorelin is a research compound, not an approved medicine.
How do sermorelin and ipamorelin differ?
Sermorelin is a GHRH analogue (it acts on the GHRH receptor); ipamorelin is a selective ghrelin-receptor (GHSR) agonist. They drive growth-hormone release through two different receptors, which is why they are frequently co-studied as a complementary pair. See our Ipamorelin vs Sermorelin research comparison for the full mechanism-by-mechanism breakdown.
How quickly are sermorelin effects observed in research (before vs after)?
IGF-1 and GH-pulse changes are measurable within days to weeks in study settings, while body-composition and sleep endpoints are typically assessed over 8-24 weeks of continued research dosing. Timelines depend entirely on the protocol and endpoint measured. Reported for research context only - not a human-use claim.
What happens if you stop taking peptides?
Sermorelin and other GHRH-analogue research peptides act by prompting the pituitary to release its own growth hormone rather than supplying hormone directly, so the published literature describes the GH/IGF-1 axis returning toward its pre-treatment baseline once stimulation ends — without the shutdown associated with stopping exogenous HGH. Any effects seen in a study fade as the short-acting peptide clears. These are research observations; sermorelin is supplied for laboratory research only and is not for human use.
Is this page medical advice? Can I use Sermorelin for my health?
No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.
Where do I find Sermorelin specs, purity certificates and pricing?
Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.
Related peptide guides
Other compounds researchers often read about alongside Sermorelin.
Scientific sources & further reading
Primary literature and registries for Sermorelin, plus mainstream coverage of the peptide category. Research use only - not medical advice.
Databases & literature:
Peptides in the news:
Ready to order? View full product specs
Access concentration, batch info, variants, and current pricing on our shop.
Also known as: GRF 1-29, GHRH(1-29), Geref, Sermorelin Acetate, Growth Hormone Releasing Factor 1-29, GRF(1-29)NH2
Premium research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical with a Certificate of Analysis on every lot. Shipped lab-direct, discreet and cold-chain, worldwide. For laboratory research use only.
Shop
Learn
Company
Support
Ways to Pay
Shop by Compound
Shop by Goal
Ships worldwide
Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.
All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.
Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.
© 2026 New-U Research Compounds · new-u.io · @new.u.io